For the Quarter Ending March 2026
Guaifenesin Prices in APAC
- In China, the Guaifenesin Price Index fell by 1.01% quarter-over-quarter, reflecting softer January import offers.
- The average Guaifenesin price for the quarter was approximately USD 6371.33/MT, reflecting balanced imports and steady domestic demand.
- Guaifenesin Spot Price firmed month-on-month as extended-release grade tightness supported higher CFR offers from premium suppliers.
- Guaifenesin Price Forecast indicates moderate upside in early Q2, driven by restocking and sustained pharmaceutical procurement.
- Guaifenesin Production Cost Trend saw upward pressure from compliance and logistics costs passed through by exporters.
- Guaifenesin Demand Outlook remains firm across OTC and hospital channels, supported by National Reimbursement Drug List inclusion.
- Inventory positions stayed comfortable, yet cautious buying reduced immediate spot liquidity, influencing the Guaifenesin Price Index trajectory.
- Export availability from India, the US, and Europe remained steady, limiting sharper volatility in the Guaifenesin Price Index.
Why did the price of Guaifenesin change in March 2026 in APAC?
- Firming export offers and higher compliance costs increased landed CFR values, reducing buyers' bargaining room in March.
- Inbound container freight edged up slightly, adding marginal cost pressure and supporting sellers' firmer offer strategies.
- Steady restocking by OTC and hospital formulators lifted physical offtake, absorbing import volumes and underpinning monthly price gains.
Guaifenesin Prices in North America
- In the USA, the Guaifenesin Price Index fell by 1.48% quarter-over-quarter, driven chiefly by lower freight costs.
- The average Guaifenesin price for the quarter was approximately USD 6421.33/MT, based on CFR imports.
- Guaifenesin Spot Price strength in March reflected rapid container rate escalation feeding into CFR offers.
- Guaifenesin Production Cost Trend remained muted as guaiacol and propylene feedstocks showed steady availability throughout.
- Guaifenesin Demand Outlook stayed firm seasonally, with robust OTC call-offs sustaining import interest and ordering.
- Guaifenesin Price Forecast suggests moderate upside into April as buyers secure volumes amid logistics uncertainty.
- Guaifenesin Price Index sensitivity to container rates meant pricing shifted quickly with changing freight dynamics.
- Inventory levels at major repackers remained two to three weeks, limiting price spikes despite intermittent shelf shortages.
Why did the price of Guaifenesin change in March 2026 in North America?
- Freight surged in March, increasing landed costs and transmitting logistics inflation into CFR import quotations.
- Sustained seasonal demand for cough-and-cold formulations kept call-offs high, enabling sellers to preserve firmer offers.
- Export availability remained steady, but higher bunker surcharges and insurance premiums pressured import pricing dynamics.
Guaifenesin Prices in Europe
- In Germany, the Guaifenesin Price Index declined slightly quarter-over-quarter, reflecting easing freight conditions earlier in the quarter and balanced supply.
- Guaifenesin Spot Price firmed in March as rising container rates and logistics surcharges increased landed import costs.
- The Guaifenesin Production Cost Trend remained stable, supported by the steady availability of guaiacol and propylene feedstocks.
- The Guaifenesin Demand Outlook stayed firm, driven by seasonal demand from cough-and-cold formulations and consistent OTC consumption.
- The Guaifenesin Price Forecast indicates moderate near-term upside, supported by logistics uncertainty and continued seasonal demand.
- Inventory levels across European distributors remained moderate, typically covering a few weeks of demand, preventing sharp price spikes.
- Import flows remained steady, though higher freight and insurance costs influenced pricing and arrival schedules.
- Suppliers maintained firm offers, reflecting cost pass-through from logistics, while supply availability remained stable.
Why did the price of Guaifenesin change in March 2026 in Europe?
- Increased freight rates and higher bunker and insurance costs raised landed import prices.
- Strong seasonal demand from the pharmaceutical and OTC sectors sustained purchasing activity.
- Stable export availability combined with logistics-driven cost inflation supported firmer pricing in March.
For the Quarter Ending December 2025
Guaifenesin Prices in APAC
- In China, the Guaifenesin Price Index fell by 9.97% quarter-over-quarter, reflecting Indian export surplus pressure.
- The average Guaifenesin price for the quarter was approximately USD 6436.33/MT, reflecting CFR Shanghai average.
- Guaifenesin Spot Price weakened as port inventories rose, pressuring the Price Index through December arrivals.
- Guaifenesin Price Forecast shows modest recovery from January as buyers rebuild inventories and resume purchases.
- Guaifenesin Production Cost Trend stayed stable with flat feedstock costs, enabling exporters to trim offers.
- Guaifenesin Demand Outlook remains muted as formulators delay spot buying after earlier influenza-driven stock accumulation.
- Elevated port stocks and steady freight kept sellers competitive, keeping the Guaifenesin Price Index pressured.
- Major exporters ran operations, supporting supply continuity while buyers exercised procurement discipline ahead of Q1.
Why did the price of Guaifenesin change in December 2025 in APAC?
- Import inflows from India and the US increased availability, overwhelming domestic buying and prompting concessions.
- Buyers reduced procurement following stock accumulation, softening demand and enabling sellers to lower CFR offers.
- Stable freight and unchanged yuan meant logistics and currency did not offset weaker purchasing pressure.
Guaifenesin Prices in North America
- In the USA, the Guaifenesin Price Index fell by 10.59% quarter-over-quarter, reflecting import oversupply and CFR pressure.
- The average Guaifenesin price for the quarter was approximately USD 6518.00/MT, reflecting import parity and lower Asian FOB.
- Guaifenesin Spot Price softened as abundant Asian shipments pressured landed offers and encouraged distributor destocking.
- Guaifenesin Price Forecast indicates gradual recovery from Q1 as restocking begins and sellers seek to rebalance inventories.
- Guaifenesin Production Cost Trend benefited from lower propylene glycol and freight reductions, improving cash costs for Asian exporters.
- Guaifenesin Demand Outlook remains muted despite seasonal respiratory activity, with formulators exercising selective procurement and maintaining safety stocks.
- Guaifenesin Price Index downward pressure moderated as freight easing reduced landed parity and buyers awaited Q1 replenishment signals.
- Inventory accumulation and Los Angeles throughput constrained rallies, while exporters offered aggressive CFR discounts to clear excess stocks.
Why did the price of Guaifenesin change in December 2025 in North America?
- Sliding China-to-USA freight reduced landed import parity, directly lowering domestic CFR levels and seller asks.
- Elevated Asian export volumes and PLI production from India increased arrivals, creating oversupply in US channels.
- Domestic distributors maintained ample inventories, curbing spot purchases and prompting sellers to offer deeper discounts.
Guaifenesin Prices in Europe
- In Europe, the Guaifenesin Price Index declined quarter-over-quarter, reflecting import oversupply and pricing pressure from Asian markets.
- Guaifenesin Spot Price softened as increased arrivals from Asia encouraged distributor destocking and reduced urgency in spot procurement.
- Guaifenesin Price Forecast indicates gradual stabilization with potential recovery in early Q1 as inventory levels normalize and buying resumes.
- Guaifenesin Production Cost Trend showed easing, supported by stable feedstock prices and lower freight costs, improving supplier margins.
- Guaifenesin Demand Outlook remained subdued despite seasonal respiratory demand, as formulators relied on existing inventories and limited fresh purchases.
- Guaifenesin Price Index pressure persisted due to elevated stock levels across European hubs, restricting upward price movement.
- Inventory buildup at key ports and distribution centers constrained price recovery, while suppliers remained competitive to clear excess volumes.
- Exporters maintained steady shipment flows into Europe, offering competitive terms to manage surplus and sustain trade activity.
Why did the price of Guaifenesin change in December 2025 in Europe?
- Declining freight rates from Asia reduced landed costs, directly pressuring CFR pricing and seller offers.
- High import volumes from India and China increased availability, leading to oversupply across European markets.
- Distributors held sufficient inventories, limiting spot buying and forcing suppliers to offer discounts to stimulate demand.
For the Quarter Ending September 2025
Guaifenesin Prices in North America
- In United States, the Guaifenesin Price Index rose quarter-over-quarter in Q3 2025, driven by robust consumer demand and tightened regional supply.
- Guaifenesin production costs faced upward pressure from a 3% Consumer Price Index increase in September 2025 and a 2.6% Producer Price Index increase in August 2025.
- Strong consumer spending, indicated by a 5.42% retail sales increase in September 2025, bolstered Guaifenesin demand.
- The low 4.3% unemployment rate in September 2025 supported consumer purchasing power, positively influencing Guaifenesin demand outlook.
- Guaifenesin production capacity was constrained by a minimal 0.1% year-over-year industrial production increase in September 2025.
- Propylene and benzene feedstock costs softened in the US during Q3 2025, partially mitigating overall Guaifenesin production expenses.
- US natural gas prices rose year-over-year in Q3 2025, impacting energy costs for Guaifenesin manufacturing, though easing in September.
- Increased biopharma market sentiment and new drug approvals in Q3 2025 signaled a positive demand outlook for pharmaceutical ingredients.
Why did the price of Guaifenesin change in September 2025 in North America?
- Rising production costs were influenced by a 3% Consumer Price Index (September 2025) and 2.6% Producer Price Index (August 2025) increase.
- Strong consumer demand, evidenced by a 5.42% retail sales increase in September 2025, supported higher Guaifenesin prices.
- Tightened regional chemical supply in Q3 2025 due to maintenance projects contributed to upward price movement.
Guaifenesin Prices in APAC
- In China, Guaifenesin prices fell in Q3 2025, influenced by weak consumer demand and declining producer prices.
- Guaifenesin production costs trended downward in Q3 2025, as natural gas prices in China moderated.
- The Consumer Price Index declined 0.3% year-over-year in September 2025, reflecting weak consumer demand for OTC remedies.
- The Producer Price Index decreased 2.3% year-over-year in September 2025, pressuring Guaifenesin market prices downward.
- China's Manufacturing Index was contracting in September 2025, impacting pharmaceutical production supply chain efficiency.
- Industrial Production grew 6.5% year-over-year in September 2025, supporting stable Guaifenesin supply availability.
- Retail Sales increased 3% year-over-year in September 2025, indicating healthy consumer spending on health products.
- Consumer confidence registered 89.6 in September 2025, reflecting a pessimistic outlook and cautious spending.
- China's LNG import volumes declined in Q3 2025, aligning with moderated natural gas prices affecting production.
Why did the price of Guaifenesin change in September 2025 in APAC?
- Weak consumer demand (Consumer Price Index down 0.3% YoY in September 2025) pressured Guaifenesin prices.
- Falling producer prices (Producer Price Index down 2.3% YoY in September 2025) reduced costs and market prices.
- Contracting Manufacturing Index and low consumer confidence (89.6) in September 2025 softened the market.
Guaifenesin Prices in Europe
- In Germany, the Guaifenesin Price Index fell quarter-over-quarter in Q3 2025, influenced by declining producer prices.
- Guaifenesin production costs saw mixed trends; producer prices fell 1.7% in September 2025.
- Benzene feedstock costs sharply declined in August 2025, while industrial energy costs remained elevated in Q3 2025.
- Guaifenesin demand outlook was mixed, as industrial production declined 1% in September 2025.
- However, demand for guaiacol in the pharmaceutical sector, including for guaifenesin, showed growth in Q3 2025.
- Retail sales increased 0.2% in September 2025, reflecting stable consumer spending on essential health products.
- Phenol inventory levels surged in Germany and the Netherlands in Q3 2025, creating an oversupply.
- The Guaifenesin Price Index is forecast to remain stable, influenced by balanced cost pressures and demand signals.
Why did the price of Guaifenesin change in September 2025 in Europe?
- Producer prices declined 1.7% in September 2025, reducing input costs for Guaifenesin manufacturing.
- Contracting industrial production and surging phenol inventory in Q3 2025 exerted downward pressure.
- High industrial energy costs in Q3 2025 partially offset lower feedstock prices, influencing overall costs.
